Nifedipine protects against overproduction of superoxide anion by monocytes from patients with systemic sclerosis

We have reported previously that dihydropyridine-type calcium-channel antagonists (DTCCA) such as nifedipine decrease plasma markers of oxidative stress damage in systemic sclerosis (SSc). To clarify the cellular basis of these beneficial effects, we investigated the effects in vivo and in vitro of...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Allanore, Yannick, Borderie, Didier, Périanin, Axel, Lemaréchal, Hervé, Ekindjian, Ohvanesse Garabed, Kahan, André
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2005
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC1064885/
https://ncbi.nlm.nih.gov/pubmed/15642147
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/ar1457
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares